AbbySarane 發表於 2026-7-23 14:43:31

Cu) Outcomes, threats, and benefits

Its impacts, nonetheless, are still being studied with various study, which is why ghk-cu copper peptide dosing has actually not been accepted by the FDA since yet.
頁: [1]
查看完整版本: Cu) Outcomes, threats, and benefits